Mojahed Shalabi

Surgical considerations in post–programmed cell death-1 therapy for cutaneous squamous cell carcinoma

Cutaneous squamous cell carcinoma (cSCC) can present as advanced disease requiring systemic therapy. Programmed cell death-1 (PD-1) inhibitors such as cemiplimab enable significant tumor regression. We report a patient with advanced cSCC who achieved near-complete remission after...